Advanced in Peptic Ulcer

Yaseen M. Arabi

CHU La Cavale Blanche
Brest, FR 
Advanced in Peptic Ulcer
CHU La Cavale Blanche
Brest, FR 
OverviewLocationsClinical Research

Overview

Yaseen Arabi practices in Brest, France. Mr. Arabi is rated as an Advanced expert by MediFind in the treatment of Peptic Ulcer. His top areas of expertise are Middle East Respiratory Syndrome (MERS), Sepsis, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Craniectomy.

His clinical research consists of co-authoring 444 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Peptic Ulcer.

Gender
Male

Locations

CHU La Cavale Blanche
Brest, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study
Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Other
Study Phase: Not Applicable
Re-EValuating the Inhibition of Stress Erosions: Prophylaxis Against Gastrointestinal Bleeding in the Critically Ill (The REVISE) Trial
Re-EValuating the Inhibition of Stress Erosions: Prophylaxis Against Gastrointestinal Bleeding in the Critically Ill (The REVISE) Trial
Enrollment Status: Completed
Publish Date: September 20, 2024
Intervention Type: Drug
Study Drug: Pantoprazole
Study Phase: Phase 3
National Approach to Standardize and Improve Mechanical Ventilation Care for Critically Ill Patients in Saudi Arabia
National Approach to Standardize and Improve Mechanical Ventilation Care for Critically Ill Patients in Saudi Arabia
Enrollment Status: Completed
Publish Date: March 14, 2023
Intervention Type: Other
Stepped-wedge Cluster Randomized Controlled Trial of Electronic Early Notification of Sepsis in Hospitalized Ward Patients (SCREEN)
Stepped-wedge Cluster Randomized Controlled Trial of Electronic Early Notification of Sepsis in Hospitalized Ward Patients (SCREEN)
Enrollment Status: Completed
Publish Date: March 14, 2023
Intervention Type: Other
Study Phase: Not Applicable
Helmet Non-Invasive Ventilation for COVID-19 Patients
Helmet Non-Invasive Ventilation for COVID-19 Patients
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
TAME Cardiac Arrest Trial: Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest: A Phase III Multi-Centre Randomised Controlled Trial
TAME Cardiac Arrest Trial: Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest: A Phase III Multi-Centre Randomised Controlled Trial
Enrollment Status: Unknown
Publish Date: April 20, 2022
Intervention Type: Other
Study Phase: Not Applicable
Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial
Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial
Enrollment Status: Completed
Publish Date: October 15, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients: Feasibility Randomized Controlled Trial
Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients: Feasibility Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: January 05, 2021
Intervention Type: Dietary supplement
Study Phase: Not Applicable
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT)
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT)
Enrollment Status: Completed
Publish Date: December 17, 2020
Intervention Type: Drug
Study Phase: Phase 4
MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b: a Multicenter, Placebo-controlled, Double-blind Randomized Trial
MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b: a Multicenter, Placebo-controlled, Double-blind Randomized Trial
Enrollment Status: Completed
Publish Date: May 20, 2020
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Prophylaxis of Thromboembolism in Critically Ill Patients Using Combined Intermittent Pneumatic Compression(IPC) and Pharmacologic Prophylaxis Versus Pharmacologic Prophylaxis Alone: A Multicenter Randomized Controlled Trial
Prophylaxis of Thromboembolism in Critically Ill Patients Using Combined Intermittent Pneumatic Compression(IPC) and Pharmacologic Prophylaxis Versus Pharmacologic Prophylaxis Alone: A Multicenter Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: December 11, 2018
Intervention Type: Device
Study Phase: Not Applicable
Invasive Candidiasis in Critically Ill Patients in Saudi Arabia: A Prospective Cohort Study
Invasive Candidiasis in Critically Ill Patients in Saudi Arabia: A Prospective Cohort Study
Enrollment Status: Completed
Publish Date: August 24, 2018
A Randomised Blinded Placebo Controlled Trial of Hydrocortisone in Critically Ill Patients With Septic Shock
A Randomised Blinded Placebo Controlled Trial of Hydrocortisone in Critically Ill Patients With Septic Shock
Enrollment Status: Completed
Publish Date: December 12, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 12 Less Clinical Trials

443 Total Publications

Outcomes of overweight and obese critically ill patients with severe acute respiratory infection.
Outcomes of overweight and obese critically ill patients with severe acute respiratory infection.
Journal: The Journal of international medical research
Published: September 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Arabi's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 25 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile